Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coagulation Disorder Neonatal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03974113
What this trial is testing

Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

Who this might be right for
Hemophilia
Genzyme, a Sanofi Company 32
Not applicableLooking for participantsNCT07101926
What this trial is testing

Monitoring of Anti-TFPI in Hemophilia

Who this might be right for
HemophiliaRebalancing AgentsProphylaxis
Hospices Civils de Lyon 11
Post-approval studies (Phase 4)Study completedNCT02727647
What this trial is testing

Comparison of Different Prophylaxis Regimens for Moderate to Severe Hemophilia A Pediatric Patients

Who this might be right for
Hemophilia A
Chulalongkorn University 16
Not applicableUnknownNCT06435533
What this trial is testing

Cold Atmospheric Plasma for the Endoscopic Treatment of Duodenal Polyps in Patients With Familial Adenomatous Polyposis

Who this might be right for
Adenomatous Polyposis ColiFamilial Adenomatous PolyposisDuodenal Adenoma
Universitätsklinikum Hamburg-Eppendorf 10
Testing effectiveness (Phase 2)Looking for participantsNCT05987449
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A

Who this might be right for
Hemophilia A
Hoffmann-La Roche 60
Not applicableStudy completedNCT01589848
What this trial is testing

Study on Von Willebrand Disease and Hemophilia in Cuenca, Ecuador

Who this might be right for
Von Willebrand DiseaseHemophilia AHemophilia B
Universidad del Azuay 81
Testing effectiveness (Phase 2)Looking for participantsNCT07640893
What this trial is testing

A Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of SR604 Injection in Patients With Von Willebrand Disease

Who this might be right for
Von Willebrand Disease (VWD)
Shanghai RAAS Blood Products Co., Ltd. 24
Large-scale testing (Phase 3)UnknownNCT06155955
What this trial is testing

Comparison of Outcomes Between Low Dose Emicizumab and Factor VIII in Clinically Severe Hemophilia A

Who this might be right for
Severe Hemophilia A Without InhibitorJoint Bleed
Chulalongkorn University 15
Not applicableStudy completedNCT05248594
What this trial is testing

Real World Use of Emicizumab in Infants and Children Ages 0-3 Years With Hemophilia A

Who this might be right for
Hemophilia A
Montefiore Medical Center 71
Not applicableLooking for participantsNCT06816056
What this trial is testing

Manual Therapy in Hemophilic Arthropathy of the Ankle

Who this might be right for
Hemophilia A
Investigación en Hemofilia y Fisioterapia 13
Not applicableStudy completedNCT00805051
What this trial is testing

Acquired Von Willebrand Syndrome in Severe Aortic Stenosis

Who this might be right for
BleedingVon Willebrand DiseaseAortic Stenosis
University Hospital, Basel, Switzerland 60
Not applicableStudy completedNCT06064851
What this trial is testing

Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Patients With and Without Von Willebrand Disease

Who this might be right for
Von Willebrand Disease, Type 1Heavy Menstrual Bleeding
Five Liters, Inc. 29
Not applicableStudy completedNCT02064933
What this trial is testing

Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990

Who this might be right for
Wiskott-Aldrich Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 305
Not applicableUnknownNCT05434728
What this trial is testing

Characterization of Bleeding Disorders in EDS

Who this might be right for
Ehlers-Danlos SyndromeEDSClassical Ehlers-Danlos Syndrome+5 more
University Health Network, Toronto 45
Not applicableUnknownNCT02199639
What this trial is testing

Transcultural Multidisciplinary Evaluation of Patients With Hemophili

Who this might be right for
Patients With Haemophilia
Universidad Católica San Antonio de Murcia 100
Testing effectiveness (Phase 2)Study completedNCT00089011
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more
Fred Hutchinson Cancer Center 150
Not applicableNot Yet RecruitingNCT06619093
What this trial is testing

Relationship Between Biological Phenotype, Clinical Severity of Sickle Cell Disease, and Blood Coagulation

Who this might be right for
Sickle Cell Disease (SCD)
Hospices Civils de Lyon 200
Not applicableNot Yet RecruitingNCT07830693
What this trial is testing

Efanesoctocog Prophylaxis Or The Optimization Of Treatment: Real-World Experience Of Taylorizing Clotting Therapy In Hemophilia A

Who this might be right for
Hemophilia A Patient
Nantes University Hospital 553
Post-approval studies (Phase 4)WithdrawnNCT04690322
What this trial is testing

POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies

Who this might be right for
Hemophilia AFactor VIII
University of Texas Southwestern Medical Center
Not applicableEnded earlyNCT03603275
What this trial is testing

Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry & Jivi: A Nested Study Within an Existing Registry

Who this might be right for
Hemophilia A
Bayer 3
Next Page